• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗惊厥药及其他非抗精神病药物治疗痴呆患者的激越症状

Anticonvulsant and other non-neuroleptic treatment of agitation in dementia.

作者信息

Tariot P N, Schneider L S, Katz I R

机构信息

Department of Psychiatry, University of Rochester School of Medicine and Dentistry, New York, USA.

出版信息

J Geriatr Psychiatry Neurol. 1995 Oct;8 Suppl 1:S28-39. doi: 10.1177/089198879500800105.

DOI:10.1177/089198879500800105
PMID:8561842
Abstract

Studies have shown that the vast majority of patients with dementia experience some psychopathologic symptoms during the course of their illness. Symptoms of this nature, which can include frightening hallucinations or anxiety of phobic proportions, are subjectively distressing and can lead both to unsafe or violent situations as well as to the preventable use of inappropriate medication, physical restraint, and frequently to institutionalization. These psychopathologic manifestations of dementia often prove to be a burden on family, caregivers, and the health care system as well. This article presents an overview of the assessment and management of agitation as it relates to the severity of dementia symptoms and cognitive deterioration. Specifically, the use of anticonvulsant and other non-neuroleptic therapies is examined.

摘要

研究表明,绝大多数痴呆患者在病程中会出现一些精神病理症状。这类症状包括令人恐惧的幻觉或达到恐惧症程度的焦虑,会给患者带来主观痛苦,既可能导致不安全或暴力情况,也可能导致不当用药、身体约束等可预防的情况,还常常导致患者被送进养老院。痴呆的这些精神病理表现往往也给家庭、护理人员和医疗保健系统带来负担。本文概述了与痴呆症状严重程度和认知衰退相关的激越的评估与管理。具体而言,探讨了抗惊厥药物及其他非抗精神病药物疗法的使用。

相似文献

1
Anticonvulsant and other non-neuroleptic treatment of agitation in dementia.抗惊厥药及其他非抗精神病药物治疗痴呆患者的激越症状
J Geriatr Psychiatry Neurol. 1995 Oct;8 Suppl 1:S28-39. doi: 10.1177/089198879500800105.
2
Treatment strategies for agitation and psychosis in dementia.痴呆症中激越和精神病的治疗策略。
J Clin Psychiatry. 1996;57 Suppl 14:21-9.
3
Pharmacologic approach to management of agitation associated with dementia.
J Clin Psychiatry. 1994 Feb;55 Suppl:13-7.
4
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.西酞普兰与利培酮治疗痴呆相关行为和精神病性症状的双盲对照研究。
Am J Geriatr Psychiatry. 2007 Nov;15(11):942-52. doi: 10.1097/JGP.0b013e3180cc1ff5. Epub 2007 Sep 10.
5
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.治疗痴呆激越的药物治疗:系统评价和网络荟萃分析。
Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456. doi: 10.1111/bcp.13604. Epub 2018 May 14.
6
Alternatives to atypical antipsychotics for the management of dementia-related agitation.用于管理痴呆相关激越的非典型抗精神病药物的替代药物。
Drugs Aging. 2008;25(5):381-98. doi: 10.2165/00002512-200825050-00003.
7
Treatment of the agitated demented elderly patient.老年痴呆躁动患者的治疗。
Hosp Community Psychiatry. 1988 Nov;39(11):1143-4. doi: 10.1176/ps.39.11.1143.
8
Pharmacologic treatment of agitation in dementia: a comprehensive review.痴呆症激越的药物治疗:全面综述
J Geriatr Psychiatry Neurol. 1996 Jul;9(3):107-19. doi: 10.1177/089198879600900301.
9
Agitation and psychosis in dementia.痴呆中的激越与精神病性症状
Am J Geriatr Psychiatry. 2007 Nov;15(11):913-7. doi: 10.1097/JGP.0b013e3181584268.
10
[Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].痴呆行为和心理症状(BPSD)患者的抗精神病药物治疗
Seishin Shinkeigaku Zasshi. 2007;109(7):657-63.

引用本文的文献

1
Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011-2014.美国长期护理中抗精神病药物和心境稳定剂处方趋势:2011 - 2014年
J Am Med Dir Assoc. 2020 Nov;21(11):1629-1635.e8. doi: 10.1016/j.jamda.2020.05.039. Epub 2020 Jul 18.
2
Neuropsychiatric Symptoms in Mild Cognitive Impairment.轻度认知障碍中的神经精神症状
Can J Psychiatry. 2017 Mar;62(3):161-169. doi: 10.1177/0706743716648296.
3
Gabapentin in the treatment of dementia-associated nocturnal agitation.加巴喷丁治疗痴呆相关性夜间激越。
Med Sci Monit. 2011 Dec;17(12):CS149-51. doi: 10.12659/msm.882114.
4
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.神经精神问卷-临床医生评定量表(NPI-C):修订版痴呆患者神经精神症状评估的信度和效度。
Int Psychogeriatr. 2010 Sep;22(6):984-94. doi: 10.1017/S1041610210000876. Epub 2010 Jul 1.
5
Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence.加巴喷丁在治疗痴呆症行为和心理症状中的应用:证据综述
Drugs Aging. 2008;25(3):187-96. doi: 10.2165/00002512-200825030-00002.
6
Neuroprotective properties of valproate: potential benefit for AD and tauopathies.丙戊酸盐的神经保护特性:对阿尔茨海默病和tau蛋白病的潜在益处。
J Mol Neurosci. 2002 Dec;19(3):303-7. doi: 10.1385/jmn:19:3:301.
7
Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.老年痴呆患者精神病和激越状态的药物治疗:四十年经验
Drugs Aging. 2002;19(4):257-76. doi: 10.2165/00002512-200219040-00002.
8
Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.痴呆行为和心理症状治疗中的临床与经济因素
Drugs Aging. 2001;18(7):527-50. doi: 10.2165/00002512-200118070-00006.
9
Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients.成人精神科住院患者明显激越严重程度量表的信度和效度
Psychiatr Q. 1998 Winter;69(4):301-23. doi: 10.1023/a:1022182114925.